Company / Working Capital per Share
Arcutis Biotherapeutics, Inc. Working Capital per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$2.39
FY2025
5-year range
$2.39 / $7.48
FY2021-FY2025
Trend
-9.3%
vs FY2024
Sector context
#156 of 210
Health Care
What the data says
At $2.39, Arcutis Biotherapeutics, Inc.'s working capital per share ranks #156 of 210 in the Health Care sector. Working Capital per Share has declined for 6 consecutive years, from $54.92 in FY2019 to $2.39 in FY2025.
Based on SEC 10-K filings.
2.39 in FY2025 with a 5-year CAGR of -20.6%.
Declined from $4.09 to $2.39 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -31.0%
- 5-Year CAGR
- -20.6%
- 10-Year CAGR
- -
Sector benchmark
#156 of 210 in Health CareTop 74% of 210This company $2.39 Sector average $118.60
▼
-98.0% below sector average
Key checks
Key Insights
- Arcutis Biotherapeutics, Inc.'s working capital per share has declined for 6 consecutive years.
- In FY2025, working capital per share decreased 9.3% year-over-year.
- Ranks #156 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.39 | -9.3% |
| FY2024 | $2.63 | -35.7% |
| FY2023 | $4.09 | -43.6% |
| FY2022 | $7.26 | -2.9% |
| FY2021 | $7.48 | -1.3% |
| FY2020 | $7.58 | -86.2% |
| FY2019 | $54.92 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026